129 related articles for article (PubMed ID: 14552718)
1. [Relationship between aberrant FHIT transcripts and hepatocellular carcinoma].
Yu YC; Sun FY; Li Z; Lu SY; Teng XH
Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):550-1. PubMed ID: 14552718
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
3. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
[TBL] [Abstract][Full Text] [Related]
4. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
5. [Abnormal expression of the FHIT gene in human primary gastrointestinal cancers].
Duan XM; Zhang GY; Wu ES
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):331-3. PubMed ID: 12205991
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
[TBL] [Abstract][Full Text] [Related]
7. Aberrant FHIT transcripts in hepatocellular carcinomas.
Chen YJ; Chen PH; Chang JG
Br J Cancer; 1998; 77(3):417-20. PubMed ID: 9472637
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the FHIT gene in human hepatocellular carcinoma.
Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
[TBL] [Abstract][Full Text] [Related]
9. Alterations of tumour suppressor gene PPP2R1B in hepatocellular carcinoma.
Chou HC; Chen CH; Lee HS; Lee CZ; Huang GT; Yang PM; Lee PH; Sheu JC
Cancer Lett; 2007 Aug; 253(1):138-43. PubMed ID: 17324501
[TBL] [Abstract][Full Text] [Related]
10. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration].
Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY
Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436
[TBL] [Abstract][Full Text] [Related]
11. bcl 10 gene mutation in hepatocellular carcinoma.
Cheng J; Leng X; Cai S; Cao Z; Cao G; Peng J; Wang S; Du R
Chin Med J (Engl); 2001 Jul; 114(7):747-51. PubMed ID: 11780342
[TBL] [Abstract][Full Text] [Related]
12. Multiple molecular alterations of FHIT in betel-associated oral carcinoma.
Chang KW; Kao SY; Tzeng RJ; Liu CJ; Cheng AJ; Yang SC; Wong YK; Lin SC
J Pathol; 2002 Mar; 196(3):300-6. PubMed ID: 11857493
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
Yu HG; Shun LB; Luo HS; Huang H; Yu BP; Yu JP; Meier JJ; Schrader H; Bastian A; Schmitz F; Schmidt WE
Int J Colorectal Dis; 2002 Nov; 17(6):396-401. PubMed ID: 12355215
[TBL] [Abstract][Full Text] [Related]
14. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
[TBL] [Abstract][Full Text] [Related]
15. Abnormal FHIT transcripts found in both lung cancer and normal lung tissue.
Tokuchi Y; Kobayashi Y; Hayashi S; Hayashi M; Tanimoto K; Hashimoto T; Nishida K; Ishikawa Y; Nakagawa K; Satoh Y; Yamamoto M; Tsuchiya E
Genes Chromosomes Cancer; 1999 Feb; 24(2):105-11. PubMed ID: 9885976
[TBL] [Abstract][Full Text] [Related]
16. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
[TBL] [Abstract][Full Text] [Related]
17. [FHIT gene is abnormal in Chinese lung cancers].
Zhang J; Fu W; Zhang X
Zhonghua Yi Xue Za Zhi; 1999 Aug; 79(8):592-5. PubMed ID: 11715406
[TBL] [Abstract][Full Text] [Related]
18. [Frequent loss of fragile histidine triad gene transcripts in lung cancer].
Wang X; Sun Y; Li W; Wang X; Ding F; Wu M
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):159-62. PubMed ID: 11812370
[TBL] [Abstract][Full Text] [Related]
19. Abnormal transcripts of FHIT gene in thyroid cancer.
Chang TJ; Tsai TC; Wu YL; Yang HM; Chi CW; Yang AH; Lee CH
Oncol Rep; 1998; 5(1):245-7. PubMed ID: 9458330
[TBL] [Abstract][Full Text] [Related]
20. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]